Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

von Willebrand Factor multimers profiling with a semi-automated system.

Pasotti F, Martini G, Caimi L, Ricotta D.

Electrophoresis. 2013 Mar;34(6):818-24. doi: 10.1002/elps.201200538.

PMID:
23334940
2.

Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.

Aihara M, Sawada Y, Ueno K, Morimoto S, Yoshida Y, de Serres M, Cooper HA, Wagner RH.

Thromb Haemost. 1986 Apr 30;55(2):263-7.

PMID:
3087003
3.
4.

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.

Studt JD, Budde U, Schneppenheim R, Eisert R, von Depka Prondzinski M, Ganser A, Barthels M.

Am J Clin Pathol. 2001 Oct;116(4):567-74.

PMID:
11601142
5.

Visualization of von Willebrand factor multimers by enzyme-conjugated secondary antibodies.

Brosstad F, Kjønniksen I, Rønning B, Stormorken H.

Thromb Haemost. 1986 Apr 30;55(2):276-8.

PMID:
3520939
6.

Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging.

Pruthi RK, Daniels TM, Heit JA, Chen D, Owen WG, Nichols WL.

Thromb Res. 2010 Dec;126(6):543-9. doi: 10.1016/j.thromres.2010.09.015.

PMID:
20889192
8.

Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection.

Ott HW, Griesmacher A, Schnapka-Koepf M, Golderer G, Sieberer A, Spannagl M, Scheibe B, Perkhofer S, Will K, Budde U.

Am J Clin Pathol. 2010 Feb;133(2):322-30. doi: 10.1309/AJCPZSBTD2BWOMVL.

PMID:
20093243
9.

Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay.

Chen D, Tange JI, Meyers BJ, Pruthi RK, Nichols WL, Heit JA.

J Thromb Haemost. 2011 Oct;9(10):1993-2002. doi: 10.1111/j.1538-7836.2011.04460.x.

11.

Chemiluminographic detection of von Willebrand factor multimeric composition.

Wen LT, Smolec JM, Coughlin J, McPherson RA.

J Clin Lab Anal. 1993;7(6):317-23.

PMID:
8277355
12.

Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.

Budde U, Pieconka A, Will K, Schneppenheim R.

Semin Thromb Hemost. 2006 Jul;32(5):514-21.

PMID:
16862525
13.

von Willebrand factor ristocetin cofactor (VWF:RCo) assay: implementation on an automated coagulometer (ACL).

Redaelli R, Corno AR, Borroni L, Mostarda G, Nichelatti M, Morra E, Baudo F.

J Thromb Haemost. 2005 Dec;3(12):2684-8.

14.
15.
16.

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors.

Casonato A, Pontara E, Bertomoro A, Dannhauser D, Secchiero S, Zaninotto M, Girolami A.

Ann Hematol. 1995 Oct;71(4):189-94.

PMID:
7578526
17.

Native multimer analysis of plasma and platelet von Willebrand factor compared to denaturing separation: implication for the interpretation of satellite bands.

Hohenstein K, Griesmacher A, Weigel G, Golderer G, Ott HW.

Electrophoresis. 2011 Jun;32(13):1684-91. doi: 10.1002/elps.201000662. Epub 2011 Jun 6.

PMID:
21647922
19.

Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.

Strandberg K, Lethagen S, Andersson K, Carlson M, Hillarp A.

Clin Appl Thromb Hemost. 2006 Jan;12(1):61-7.

PMID:
16444436
20.

A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.

Casonato A, Pontara E, Dannhäuser D, Bertomoro A, Sartori MT, Girolami A.

Haematologia (Budap). 1994;26(2):97-109.

PMID:
7890268

Supplemental Content

Support Center